Bright Minds Biosciences Inc. (DRUG) stock
DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
$20.76+0.25 (+1.22%)
Close on Nov 18, 2026Market cap $158.52MP/E –Yield –
Bright Minds Biosciences cash
Cash and short-term investments held at the end of each period.
Bright Minds Biosciences's cash was C$82.91M at Sep 30, 2025. For fiscal 2025 it was C$82.91M, up 1349.4% from the year before. The highest annual figure on record is C$82.91M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | C$82.91M | +1349.4% |
| FY2024 | Sep 30, 2024 | C$5.72M | -15.2% |
| FY2023 | Sep 30, 2023 | C$6.75M | -42.0% |
| FY2022 | Sep 30, 2022 | C$11.63M | -41.2% |
| FY2021 | Sep 30, 2021 | C$19.76M | +2370.2% |
| FY2020 | Sep 30, 2020 | C$799.93K | +900.0% |
| FY2019 | Sep 30, 2019 | C$79.99K | – |
| FY2018 | Sep 30, 2018 | C$0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | C$82.91M | +319.6% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | C$5.72M | +615.1% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | C$6.75M | +8335.9% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | C$11.63M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | C$19.76M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | C$799.93K | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | C$79.99K | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | C$0 | – |
See a number that looks wrong?